NRIX Message Board Post 10011644 | Nurix Therapeutics Inc.
home / stock / nrix / nrix message board
catskiller2
(investorshub)
Posted on: Mar/24/2021 19:21:29
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162769688
what the F is wrong with this fkn
News, Short Squeeze, Breakout and More Instantly...
-
2024-07-12 17:15:01 ET Oppenheimer analyst issues OUTPERFORM recommendation for NRIX on July 12, 2024 03:19PM ET. The previous analyst recommendation was Outperform. NRIX was trading at $23.82 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
-
Presented positive clinical data at the European Hematology Association Congress supporting a potential best-in-class profile for NX-5948 for the treatment of CLL Strengthened leadership with appointment of Paula G. O’Connor, M.D., as chief medical officer and Pasit Phiasivongsa,...
-
SAN FRANCISCO, July 08, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced that Arthur T. Sands, M.D., Ph.D., pr...